{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:02Z","timestamp":1707525302099},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.7759\/cureus.46339","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:53:22Z","timestamp":1696226002000},"source":"Crossref","is-referenced-by-count":1,"title":["Anaplastic Lymphoma Kinase (ALK)-Rearranged Lung Cancer That Showed Exclusively Scattered Isolated Cells Devoid of Mucin Production in Cytology"],"prefix":"10.7759","author":[{"given":"Tsuyoshi","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000361","article-title":"Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients","volume":"9","author":"Vidal J","year":"2014","unstructured":"Vidal J, Clav\u00e9 S, de Muga S, et al.. Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients. J Thorac Oncol. 2014, 9:1816-20. 10.1097\/JTO.0000000000000361","journal-title":"J Thorac Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311107","article-title":"Ceritinib in ALK-rearranged non-small-cell lung cancer","volume":"370","author":"Shaw AT","year":"2014","unstructured":"Shaw AT, Kim DW, Mehra R, et al.. Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med. 2014, 370:1189-97. 10.1056\/NEJMoa1311107","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak EL","year":"2010","unstructured":"Kwak EL, Bang YJ, Camidge DR, et al.. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010, 363:1693-703. 10.1056\/NEJMoa1006448","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076999","article-title":"A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype","volume":"8","author":"Kim H","year":"2013","unstructured":"Kim H, Jang SJ, Chung DH, et al.. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype. PLoS One. 2013, 8:e76999. 10.1371\/journal.pone.0076999","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.07.017","article-title":"ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma","volume":"75","author":"Popat S","year":"2012","unstructured":"Popat S, Gonzalez D, Min T, et al.. ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma. Lung Cancer. 2012, 75:300-5. 10.1016\/j.lungcan.2011.07.017","journal-title":"Lung Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21507","article-title":"Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells","volume":"123","author":"Pareja F","year":"2015","unstructured":"Pareja F, Crapanzano JP, Mansukhani MM, Bulman WA, Saqi A. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells. Cancer Cytopathol. 2015, 123:162-70. 10.1002\/cncy.21507","journal-title":"Cancer Cytopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23800","article-title":"Cytological markers for predicting ALK-positive pulmonary adenocarcinoma","volume":"45","author":"Miyata K","year":"2017","unstructured":"Miyata K, Morita S, Dejima H, et al.. Cytological markers for predicting ALK-positive pulmonary adenocarcinoma. Diagn Cytopathol. 2017, 45:963-70. 10.1002\/dc.23800","journal-title":"Diagn Cytopathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23879","article-title":"Cytological features in eight patients with ALK-rearranged lung cancer","volume":"46","author":"Kuroda N","year":"2018","unstructured":"Kuroda N, Ohara M, Wada Y, et al.. Cytological features in eight patients with ALK-rearranged lung cancer. Diagn Cytopathol. 2018, 46:516-9. 10.1002\/dc.23879","journal-title":"Diagn Cytopathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg M","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009, 119:1429-37. 10.1172\/JCI36183","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in cancer-a review","volume":"21","author":"Kaszak I","year":"2020","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of cadherins in cancer-a review. Int J Mol Sci. 2020, 21:7624. 10.3390\/ijms21207624","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8955","article-title":"Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1","volume":"7","author":"Voena C","year":"2016","unstructured":"Voena C, Varesio LM, Zhang L, et al.. Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1. Oncotarget. 2016, 7:33316-30. 10.18632\/oncotarget.8955","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor JF","year":"2016","unstructured":"Gainor JF, Dardaei L, Yoda S, et al.. Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer. Cancer Discov. 2016, 6:1118-33. 10.1158\/2159-8290.CD-16-0596","journal-title":"Cancer Discov"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1123","article-title":"Targeting ALK: Precision medicine takes on drug resistance","volume":"7","author":"Lin JJ","year":"2017","unstructured":"Lin JJ, Riely GJ, Shaw AT. Targeting ALK: Precision medicine takes on drug resistance. Cancer Discov. 2017, 7:137-55. 10.1158\/2159-8290.CD-16-1123","journal-title":"Cancer Discov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187072-anaplastic-lymphoma-kinase-alk-rearranged-lung-cancer-that-showed-exclusively-scattered-isolated-cells-devoid-of-mucin-production-in-cytology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:19Z","timestamp":1707509419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187072-anaplastic-lymphoma-kinase-alk-rearranged-lung-cancer-that-showed-exclusively-scattered-isolated-cells-devoid-of-mucin-production-in-cytology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.46339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}